Abstract
Increased emphasis on patient empowerment and the growing interest in patient–centred care have encouraged health-care professionals and researchers to incorporate patient-reported outcomes such as quality of life (QoL) measures in routine clinical practice and outcome research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Haliousa B, Beumont MG, Lunel F. Quality of life in dermatology. Int J Dermatol. 2000;39:801–6.
Augustin M, Amon U, Bullinger M, Gieler U. Recommendations for the assessment of quality of life in dermatology. Dermatol Psychosom. 2000;1:84–7.
Guyatt GH, Veldhuyzen SJ, Feeny DH, Patrick DL. Measuring quality of life in clinical trials: a taxonomy and review. Can Med Assoc J. 1989;140:1441–8.
Levin MN, Ganz PA. Beyond the development of quality of life instruments: where do we go from here? J Clin Oncol. 2002;20:2215–6.
de Korte J, Sprangers MAG, Mombers FMC, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Invest Dermatol. 2004;9:140–7.
Jenney ME, Campbell S. Measuring quality of life. Arch Dis Child. 1997;77:347–54.
EuroQoL Group. EQ-5D user guide: a measure of health-related quality of life developed by the EuroQoL Group. Rotterdam Centre for Health Policy and Law, Erasmus University, Rotterdam; 1996.
Klassen AF, Newton JN, Mallon E. Measuring quality of life in people referred for specialist care of acne: comparing generic and disease-specific measures. J Am Acad Dermatol. 2000;43:229–33.
Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. Br Med J. 1998;316:736–41.
Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.
Mallon E, Newton JN, Klassen A, et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140:672–6.
Goldberg D, Williams P. A user’s guide to the general health questionnaire. Windsor: NFER-Nelson; 1988.
Newton JN, Mallon E, Klassen A, et al. The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol. 1997;137:563–7.
Hayashi N, Imori M, Yanagisawa M, et al. Make-up improves the quality of life of acne patients without aggravating acne eruptions during treatments. Eur J Dermatol. 2005;15:284–7.
Salek MS, Khan GK, Finlay AY. Questionnaire techniques in assessing acne handicap: reliability and validity study. Qual Life Res. 1996;5:131–8.
Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981;19:787–805.
Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118:622–9.
Torrance GW. Utility approach to measuring health related quality of life. J Chronic Dis. 1987;40:593–600.
McCombs K, Chen SC. Patient preference quality of life measures in dermatology. Dermatol Ther. 2007;20:102–9.
Littenberg B, Partilo S, Licata A, Kattan MW. Paper Standard Gamble: the reliability of a paper questionnaire to assess utility. Med Decis Making. 2003;23:480–8.
Chen SC, Bayoumi AM, Soon SL, et al. A catalog of dermatology utilities: a measure of the burden of skin diseases. J Investig Dermatol Symp Proc. 2004;9:160–8.
Simpson NB. Social and economic aspects of acne and the cost-effectiveness of isotretinoin. J Dermatol Treat. 1993;4 suppl 2:S6–9.
Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dermatol. 1989;14:194–8.
de Korte J, Femke MA, Mombers MC, et al. The suitability of quality of life questionnaires for psoriasis research. Arch Dermatol. 2002;138:1221–7.
Le Cleach L, Chassany O, Levy A, Wolkenstein P, Chosidow O. Poor reporting of quality of life outcomes in dermatology randomized controlled clinical trials. Dermatology. 2008;216:46–55.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.
Basra MKA, Fenech R, Gatt RM, et al. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol. 2008;159:997–1035.
Hongbo Y, Thomas CL, Harrison MA, Salek S, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol. 2005;125:659–64.
Ilgen E, Derya A. There is no correlation between acne severity and AQOLS/DLQI scores. J Dermatol. 2005;32:705–10.
Zaghloul SS, Cunliffe WJ, Goodfield MJD. Objective assessment of compliance with treatments in acne. Br J Dermatol. 2005;152:1015–21.
Boehncke WH, Ochsendorf F, Paeslack I, et al. Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases. Eur J Dermatol. 2002;12:577–80.
Chren MM, Lasek RJ, Quin LM, et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107:707–13.
Chren MM, Lasek RJ. Skindex 1.1: reliability, validity and responsiveness of a refined instrument to measure the effect of skin disease on quality of life. J Invest Dermatol. 1997;108:366. abstract.
Chren MM, Lasek RJ, Flocke SA, et al. Improved discriminative and evaluative capability of a refined version of Skindex: a quality of life instrument for patients with skin diseases. Arch Dermatol. 1997;133:1433–40.
Chren MM, Lasek RJ, Sahay AP, Sands LP. Measurement properties of Skindex-16: a brief quality of life measure for patients with skin diseases. J Cutan Med Surg. 2001;5:105–10.
Nijsten TEC, Sampogna F, Chren MM, Abeni DD. Testing and reducing skindex-29 using Rasch analysis: skindex-17. J Invest Dermatol. 2006;126:1244–50.
Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol. 1998;134:454–8.
Jones-Caballero M, Chren MM, Soler B, et al. Quality of life in mild to moderate acne: relationship to clinical severity and factors influencing change with treatment. J Eur Acad Dermatol Venereol. 2007;21:219–26.
Rapp DA, Brenes GA, Feldman SR, et al. Anger and acne: implications for quality of life, patient satisfaction and clinical care. Br J Dermatol. 2004;151:183–9.
Morgan M, McCreedy R, Simpson J, Hay R. Dermatology quality of life scales – a measure of the impact of skin diseases. Br J Dermatol. 1997;136:202–6.
Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol. 1997;37:41–50.
Rajagopalan R, Anderson RT, Sherertz EF, Edwards L. Quality of life evaluation in chronic lichen sclerosus for improved medical care. Drug Inf J. 1999;33:577–84.
Anderson R, Rajagopalan R. Responsiveness of the Dermatology-specific Quality of Life (DSQL) instrument to treatment for acne vulgaris in a placebo-controlled clinical trial. Qual Life Res. 1998;7:723–34.
Mosam A, Vawda NB, Gordhan AH, et al. Quality of life issues for South Africans with acne vulgaris. Clin Exp Dermatol. 2005;30:6–9.
Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132:942–9.
Holme AS, Man I, Sharpe JL, et al. The Children’s Dermatology Life Quality Index: validation of the cartoon version. Br J Dermatol. 2003;148:285–90.
Walker N, Lewis-Jones MS. Quality of life and acne in Scottish adolescent schoolchildren: use of the Children’s Dermatology Life Quality Index© (CDLQI) and the Cardiff Acne Disability Index© (CADI). J Eur Acad Dermatol Venereol. 2006;20:45–50.
Wiebe S, Guyatt G, Weaver B, et al. Comparative responsiveness of generic and specific quality of life instruments. J Clin Epidemiol. 2003;56:52–60.
Hays RD. Generic versus disease-targeted instruments. In: Fayers P, Hays R, editors. Assessing quality of life in clinical trials. 2nd ed. New York: Oxford University Press; 2005. p. 3–8.
Atherly A. Condition-specific measures. In: Kane RL, editor. Understanding health care outcomes research. 2nd ed. Boston: Jones and Bartlett; 2006. p. 165–83.
Coons SJ, Shaw JW. Generic adult health status measures. In: Fayers P, Hays R, editors. Assessing quality of life in clinical trials. 2nd ed. New York: Oxford University Press; 2005. p. 325–8.
Lim CCL, Tan TC. Personality, disability and acne in college students. Clin Exp Dermatol. 1991;16:371–3.
Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol. 1992;17:1–3.
Oakley A. The Acne Disability Index-usefulness confirmed. Aust J Dermatol. 1996;37:37–9.
Dreno B, Finaly AY, Nocera T, et al. The Cardiff Acne Disability Index: cultural and linguistic validation in French. Dermatology. 2004;208:104–8.
Girman CJ, Hartmaier S, Thiboutot D, et al. Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials. Qual Life Res. 1996;5:481–90.
Martin AR, Lookingbill DP, Botek A, et al. Health-related quality of life among patients with facial acne-assessment of a new acne-specific questionnaire. Clin Exp Dermatol. 2001;26:380–5.
Fehnel SE, McLeod LD, Brandman J, et al. Responsiveness of the Acne-Specific Quality of Life Questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials. Qual Life Res. 2002;11:809–16.
McLeod LD, Fehnel SE, Brandman J, Symonds T. Evaluating minimal clinically important differences for the Acne-specific Quality of Life Questionnaire. Pharmacoeconomics. 2003;21:1069–79.
Tan J, Fung KY, Khan S. Condensation and validation of a 4-item index of the Acne-QoL. Qual Life Res. 2006;15:1203–10.
Gupta MA, Johnson AM, Gupta AK. The development of an Acne Quality of Life scale: reliability, validity, and relation to subjective acne severity in mild to moderate acne vulgaris. Acta Derm Venereol. 1998;78:451–6.
Weiss JW, Shavin J, Davis M. Preliminary results of a nonrandomized, multicenter open-label study of patient satisfaction after treatment with combination benzoyl peroxide/clinamycin topical gel for mild to moderate acne. Clin Ther. 2002;24:1706–17.
Yazici K, Baz K, Yazici AE, et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol. 2004;18:435–9.
Rapp SR, Feldman SR, Graham G, et al. The Acne Quality of Life Index (Acne-QOLI): development and validation of a brief instrument. Am J Clin Dermatol. 2006;7:185–92.
Layton AM, Eady A, Cunliffe WJ. A reassessment of acne: what constitutes severe acne? Br J Dermatol. 1991;125 Suppl 38:35–6.
Clark SM, Goulden V, Finlay AY, et al. The psychological and social impact of acne: a comparison study using three acne disability questionnaires. Br J Dermatol. 1997;137 Suppl 50:41.
McKenna KE, Stern RS. The outcomes movement and new measures of the severity of psoriasis. J Am Acad Dermatol. 1996;34:534–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Basra, M.K.A., Finlay, A.Y. (2014). Instruments of Measurement of Quality of Life in Acne. In: Zouboulis, C., Katsambas, A., Kligman, A. (eds) Pathogenesis and Treatment of Acne and Rosacea. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69375-8_74
Download citation
DOI: https://doi.org/10.1007/978-3-540-69375-8_74
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69374-1
Online ISBN: 978-3-540-69375-8
eBook Packages: MedicineMedicine (R0)